Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu Zheng
Observed name:
Zheng, Yu
Institutions:
Second Affiliated Hospital of Guangzhou Medical University,
Guangzhou Medical University
Observed institutions:
Harvard University,
Massachusetts General Hospital,
Second Affiliated Hospital of Guangzhou Medical University,
Nanfang Hospital,
Southern Medical University,
Guangzhou Medical University
show all 6
ORCID:
0000-0002-9157-8769
Observed ORCID:
0000-0002-9157-8769
OpenAlex ID:
A5101907140
Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis
2020
·
Yu Zheng
, Sharron X. Lin
, et al.
·
Cancer Medicine
·
25
PDF
The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation
2021
·
Qiwen Kuang
, Yuxiang Liang
, et al.
·
OncoTargets and Therapy
·
24
PDF
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
2020
·
Chaojiang Chen
, Zhiduan Cai
, et al.
·
BMC Cancer
·
22
PDF
LncRNA RPSAP52 regulates miR-423-5p/GSTM1 axis to suppress hypoxia-induced renal proximal tubular epithelial cell apoptosis
2020
·
Jie Chen
, Yu Zheng
, et al.
·
Archives of Physiology and Biochemistry
·
11
Differential Mechanisms Underlying Antidepressant Responses of Ketamine and Imipramine
2017
·
Zhisheng Wei
, Ke Zhang
, et al.
·
CNS & Neurological Disorders - Drug Targets
·
10
Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront
2024
·
Xiao Xiao Li
, Wen Hui Huang
, et al.
·
Molecular Medicine
·
8
PDF
Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy
2020
·
Sharron X. Lin
, Yu Zheng
, et al.
·
Scandinavian Journal of Urology
·
4
WTAP-mediated m6A modification of ARG2 mRNA Inhibits Its expression and drives prostate cancer malignant progression
2025
·
Jianxin Li
, Yu Zheng
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
2
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
2019
·
Zhuo-yuan Lin
, Guo Chen
, et al.
·
Molecular Cancer
·
2
PDF
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer
2023
·
Zhuo-yuan Lin
, Guo Chen
, et al.
·
Molecular Cancer
PDF
Study on Foxp3——924 polymorphisms in patients with allergic conjunctivitis
2014
·
Ruiming Yang
, He Lai
, et al.
·
Chinese Journal of Practical Ophthalmology
Show more works
View as search
Works count:
18
Citation count:
108
H-index:
6
I10-index:
5
Year
Topic
Type